Skip to main navigation Skip to search Skip to main content

Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations

  • Katja Kaastrup
  • , Morten Tulstrup
  • , Jakob W Hansen
  • , Claudia Schöllkopf
  • , Klas Raaschou-Jensen
  • , Andreas D Ørskov
  • , Bo Porse
  • , Peter A Jones
  • , Joachim Weischenfeldt
  • , Linn Gillberg
  • , Kirsten Grønbæk*
  • *Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

Abstract

Not available.

Original languageEnglish
Pages (from-to)1164-1169
Number of pages6
JournalHaematologica
Volume110
Issue number5
Early online date2 Jan 2025
DOIs
Publication statusPublished - 1 May 2025

Funding

The study is part of the Danish Research Center for Precision Medicine in Blood Cancers funded by the Danish Cancer Society grant number R223-A13071 and was supported by a Center grant from the Novo Nordisk Foundation (Novo Nordisk Foundation Centre for Stem Cell Biology, Dan Stem; grant number NNF17CC0027852) and Greater Copenhagen Health Science Partners, and through a grant from Dansk Kraeftforskningsfond. KK was supported by a 1 -year grant from the University of Copenhagen.

FundersFunder number
Danish Cancer SocietyR223-A13071
Novo Nordisk FoundationNNF17CC0027852
Greater Copenhagen Health Science Partners, Clinical Academic Group Prognostication of Acute Recovery Capacity - in an Aging Population
Danish Foundation for Clinical and Experimental Cancer Research
University of Copenhagen

    Keywords

    • Mutations

    Fingerprint

    Explore the research areas of 'Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations'.

    Cite this